4D Molecular Therapeutics
FDMT
FDMT
144 hedge funds and large institutions have $262M invested in 4D Molecular Therapeutics in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 50 increasing their positions, 45 reducing their positions, and 27 closing their positions.
Holders
144
Holders Change
+5
Holders Change %
+3.6%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
50
Reduced
45
Closed
27
Calls
$858K
Puts
$370K
Net Calls
+$488K
Net Calls Change
+$33K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$7.91M |
| 2 |
2
Goldman Sachs
New York
|
$23.8M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$4.57M |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$3.37M |
| 5 |
CSS
5
Cubist Systematic Strategies
Stamford,
Connecticut
|
$2.5M |
